Insider Trading March 30, 2026

Datacentrex Director Acquires $100,000 Stake as Company Prices $20.17M Offering

Director Allan Thomas Evans buys 50,000 shares at $2.00 amid a planned public offering and recent acquisition filings

By Jordan Park DTCX
Datacentrex Director Acquires $100,000 Stake as Company Prices $20.17M Offering
DTCX

Datacentrex, Inc. director Allan Thomas Evans purchased 50,000 common shares on March 26, 2026, at $2.00 per share for $100,000. The stock trades at $2.19, though it has fallen 47% over six months. The company has priced a public offering expected to raise $20.17 million and filed SEC disclosures following its acquisition of Dogehash Technologies.

Key Points

  • Director Allan Thomas Evans bought 50,000 Datacentrex shares on March 26, 2026, at $2.00 per share, a $100,000 purchase.
  • Evans now directly owns 50,000 shares and indirectly controls 103,550 additional shares via 8 Consulting LLC, where he is sole owner with voting and dispositive control.
  • Datacentrex priced a public offering of common stock and pre-funded warrants at $2.00 per share to raise expected gross proceeds of $20.17 million and filed updated SEC disclosures after acquiring Dogehash Technologies.

Datacentrex, Inc. reported a director-level purchase on March 26, 2026, when Allan Thomas Evans acquired 50,000 shares of the company's common stock at $2.00 per share, representing a $100,000 transaction. The shares are currently quoting at $2.19, modestly above Evans' purchase price, even as the stock remains down roughly 47% over the prior six-month period.

Following the trade, Evans directly holds 50,000 shares of Datacentrex common stock. He also maintains indirect ownership of 103,550 shares through 8 Consulting LLC, where he is the sole owner and retains both voting and dispositive authority over the holdings.

Market behavior around the equity has been uneven. According to InvestingPro analysis, Datacentrex stock generally exhibits high price volatility. The InvestingPro note referenced access to additional ProTips and a suite of financial metrics on the platform for investors seeking deeper data.

The insider purchase comes as Datacentrex has moved to strengthen its balance sheet. The company announced pricing of a public offering of common stock and pre-funded warrants at $2.00 per share, with expected gross proceeds of $20.17 million. The offering is targeted to close by March 30, 2026, subject to customary closing conditions. Management stated the net proceeds are intended to be used for working capital and general corporate purposes.

In regulatory filings, Datacentrex also disclosed updated information following the acquisition of Dogehash Technologies, Inc. The transaction was executed through a merger with the company’s subsidiary, TZUP Merger Sub, Inc., and Dogehash now operates as a wholly owned subsidiary of Datacentrex. These filings accompanied the company’s broader effort to expand both operations and financial resources.

The combination of an insider purchase, a near-term capital raise at the same per-share price as the director’s trade, and recent acquisition-related SEC disclosures presents a snapshot of multiple, concurrent corporate actions. Each item is factual and documented in company notices and regulatory filings; together they illustrate active corporate and financing activity at Datacentrex, though the company’s shares remain volatile and have declined materially over the six-month window noted above.


Contextual note: The details above are drawn from company-reported transactions, offering terms, and SEC disclosures. The factual record includes the director’s direct and indirect holdings, the pricing and expected gross proceeds of the public offering, the anticipated close date subject to customary conditions, and the completed merger that places Dogehash Technologies under Datacentrex ownership.

Risks

  • High historical price volatility - InvestingPro analysis indicates the stock generally trades with high volatility, which affects equity market and investor risk profiles.
  • Financing contingent on closing conditions - The public offering is expected to close by March 30, 2026, but remains subject to customary closing conditions that could delay or alter expected proceeds, impacting the company's planned use of funds.
  • Significant share price decline over six months - The stock has fallen 47% in the prior six months, reflecting market uncertainty that could influence liquidity and investor sentiment in the technology and capital markets sectors.

More from Insider Trading

Impact Biomedical CFO Disposes $25,330 in IBO Shares Across Two Trades Mar 30, 2026 Control Empresarial trims Talos Energy stake with $38.54 million share sale Mar 30, 2026 Advanced Flower Capital Director Increases Stake with $62,475 Purchase Mar 30, 2026 PBF Energy SVP Sells $2.57M in Stock After Exercising Long‑standing Options Mar 30, 2026 22NW Entities Trim Stake in L.B. Foster; Sale Coincides With Mixed Q4 2025 Results Mar 30, 2026